PAK2 and heart failure: In human iPSC-derived cardiomyocytes, PAK2 (p21-activated kinase 2) activation can enhance ER function, reduce cell apoptosis, and protect from heart failure through the IRE1α/XBP1 (X-box binding protein 1)-dependent pathway (Binder et al., 2019).